Skin and systemic disease Flashcards
Presentation of dermatomyositis - hands
Gottron’s papules - flat-topped, red, lichenoid, over MCPs and IPs
Nails - telangiectasia, ragged edges, inflammation, highly suggestive
Rash may be itchy or asymptomatic
Hx of Raynaud’s common
Presentation of dermatomyositis - non-hand
Heliotrope (purple) rash in periorbital distribution, often w/ oedema
Photosensitive rash around upper arms, chest, back (‘shawl sign’)
Symmetrical proximal myopathy
Possible scalp involvement - alopecia
Calcinosis of skin
Aetiology of dermatomyositis
Drugs - esp statins
Idiopathic
Malignancy - may precede or follow malignancy
Differential for proximal myopathy
Thyrotoxicosis
Polymyalgia rheumatica
Cushing’s
Alcohol excess
Also consider SLE or overlap w/ e.g. systemic sclerosis
Polymyositis/dermatomyositis
Investigation of dermatomyositis
ESR, CRP
CK
FBC
ANA, anti-Jo, anti-Mi
Skin/Muscle biopsy, EMG, muscle MRI
Malignancy screen?
Management of dermatomyositis
Photoprotection, rest
Systemic steroids - 0.5-1mg/kg of prednisolone
Second-line: steroid sparing e.g. HCQ, AZA, MTX
Dermatological manifestation of SLE
Malar rash, erythema, photosensitive
Raised or non-raised
Sparing nasolabial folds
Non-scarring (c.f. discoid), no pustules (c.f. rosacea)
Fine scale
Doesn’t necessarily indicate systemic involvement
Dermatological appearance of discoid lupus
Discoid rash over face, ears, scalp, chest
Progresses to hyperkeratotic, pigmented, papules appearance –> atrophic, hypopigmented scarring
Dermatological appearance of subacute lupus
Annular, polycyclic lesions
Non-scarring
May have non-indurated psoriasiform appearance
Management of SLE
Sun protection
Stop smoking
Topical steroids for localised skin disease
HCQ for systemic disease
Oral steroids for acute flare-ups
Presentation of dermatitis herpetiformis
Intensely pruritic vesicles
Extensor distribution - buttocks, knees, elbows, forehead/scalp
?coeliac
Investigation of dermatitis herpetiformis
Skin biopsy of early blister
Anti-TTG or anti-endomysial Abs
Management of dermatitis herpetiformis
PO dapsone 50-200mg - need FBC (haemolysis, agranulocytosis) and LFT (hepatitis) monitoring
GF diet
Gastro referral - increased risk of small bowel lymphoma so surveillance
Presentation of cutaneous vasculitis
Palpable, nonblanching purpura
Usually lower legs
May become necrotic/ulcerate
?symptoms of systemic vasculitis
Causes of cutaneous vasculitis
Idiopathic - not necessarily systemic
Drugs - esp abx
ANCA-assoc vasculitides
CTD e.g. SLE, RA
Infx - e.g. strep, Hep B/C, TB, leprosy